RaySearch Laboratories AB (publ)
General ticker "RSLBF" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $904.2M (TTM average)
RaySearch Laboratories AB (publ) follows the US Stock Market performance with the rate: 17.6%.
Estimated limits based on current volatility of 0.0%: low 27.61$, high 27.61$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-05-26, amount 0.31$ (Y1.12%)
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [15.73$, 27.57$]
- 2025-12-31 to 2026-12-31 estimated range: [14.66$, 26.18$]
Financial Metrics affecting the RSLBF estimates:
- Positive: with PPE of 34.5 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 21.85 > 18.64
- Negative: negative Industry operating cash flow (median)
- Positive: -4.48 < Investing cash flow per share per price, % of -3.02
- Positive: Return on assets ratio (scaled to [-100,100]) of 11.17 > 6.04
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term RSLBF quotes
Long-term RSLBF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | SEK843.65MM | SEK1,022.16MM | SEK1,192.03MM |
| Operating Expenses | SEK800.90MM | SEK907.28MM | SEK931.54MM |
| Operating Income | SEK42.74MM | SEK114.88MM | SEK260.49MM |
| Non-Operating Income | SEK-10.37MM | SEK-4.79MM | SEK2.37MM |
| Interest Expense | SEK11.48MM | SEK9.69MM | SEK8.99MM |
| R&D Expense | SEK238.77MM | SEK237.74MM | SEK269.38MM |
| Income(Loss) | SEK32.38MM | SEK110.09MM | SEK262.87MM |
| Profit(Loss)* | SEK23.78MM | SEK81.57MM | SEK203.51MM |
| Stockholders Equity | SEK657.16MM | SEK735.23MM | SEK876.71MM |
| Inventory | SEK14.09MM | SEK9.32MM | SEK10.62MM |
| Assets | SEK1,875.95MM | SEK1,952.67MM | SEK2,091.18MM |
| Operating Cash Flow | SEK356.78MM | SEK455.93MM | SEK485.23MM |
| Capital expenditure | SEK231.50MM | SEK209.33MM | SEK217.54MM |
| Investing Cash Flow | SEK-231.50MM | SEK-209.33MM | SEK-217.54MM |
| Financing Cash Flow | SEK-78.49MM | SEK-56.35MM | SEK-159.78MM |
| Earnings Per Share** | SEK0.69 | SEK2.38 | SEK5.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.